MRO Tracker · Pharma
Warning letters issued by the US FDA to Indian drug plants and testing labs in 2026, with site, letter number and the main issue. The list covers letters for drug manufacturing quality. It is a verified running log rather than a complete count: the FDA issued more letters to Indian sites over its fiscal year, and further letters are added as each one is checked.
14letters to Indian sites verified so far in 2026
5to API makers
8sites also on import alert
2contract testing labs
MRO View: API makers and testing labs make up half of the 2026 list, and eight sites were placed on import alert before or alongside the letter. The import alert is what stops shipments at the US border, while the letter can hold back new approvals from the site until it is closed.
Warning letters to Indian sites, 2026
| Issued | Company | Site | Letter no. | Key detail |
|---|---|---|---|---|
| 27 Oct 2026 | Pritam International | Bhagwanpur, Haridwar, Uttarakhand | 320-27-12 | OTC toothpaste contract maker; on Import Alert 66-40 since 3 Sep 2026 |
| 18 Aug 2026 | Reliance Life Sciences | Rabale, Navi Mumbai, Maharashtra | 320-26-117 | Sterile products; inspected 19 to 27 Feb 2026; on Import Alert 66-40 since 9 Jul 2026 |
| 18 Aug 2026 | Shoolin Pharma Chem | Indrad, Mehsana, Gujarat | 320-26-116 | API maker; inspected 13 to 17 Apr 2026; on Import Alert 66-40 since 11 Aug 2026 |
| 13 Aug 2026 | Eugia Pharma Specialities (Aurobindo), Unit 1 | Kolthur, Telangana | 320-26-115 | Sterile injectables; inspected 16 to 27 Feb 2026 |
| 12 Aug 2026 | Auriga Research (contract testing lab) | Yeshwanthpur, Bengaluru, Karnataka | 320-26-113 | Inspected 4 to 6 Feb 2026; repeat testing until results passed |
| 24 Jul 2026 | Dabur India | Saily, Silvassa, DNH and DD | 320-26-105 | OTC drugs; inspected 12 to 16 Jan 2026; on Import Alert 66-40 since 10 Jun 2026 (company filing) |
| 13 Jul 2026 | Almon Healthcare | Bavala, Ahmedabad, Gujarat | 320-26-102 | API maker; inspected 9 to 13 Feb 2026; on Import Alert 66-40 since 9 Jun 2026 |
| 13 Jul 2026 | Shimoga Chemicals | Kupwad MIDC, Sangli, Maharashtra | 320-26-101 | API maker; inspected 19 to 23 Jan 2026; on Import Alert 66-40 since 2 Jun 2026 |
| 2 Jun 2026 | Zydus Lifesciences | Baddi, Himachal Pradesh | 320-26-92 | Finished dosage plant; incoming component testing failures |
| 21 May 2026 | Alchymars ICM SM | Alathur, Tamil Nadu | 320-26-77 | API maker; unannounced inspection Nov to Dec 2025; on Import Alert 66-40 since 19 May 2026 |
| 30 Mar 2026 | Intas Pharmaceuticals | Selaqui, Dehradun, Uttarakhand | 320-26-57 | Inspected 8 to 17 Sep 2025; weak handling of out of specification assay results |
| 11 Mar 2026 | Flowchem Pharma | Hindupur, Andhra Pradesh | 320-26-51 | API maker; inspected 8 to 12 Sep 2025; on Import Alert 66-40 since 22 Jan 2026 |
| 3 Mar 2026 | Tentamus India (contract testing lab) | Kompally, Hyderabad, Telangana | 320-26-47 | Quality control unit failures |
| 30 Jan 2026 | Cohance Lifesciences | IDA Nacharam, Medchal Malkajgiri, Telangana | 320-26-40 | Tablets and capsules; inspected 4 to 12 Aug 2025; cleaning and investigation failures |
Letters to companies that only market or import products, and letters on clinical or laboratory study conduct, are not included.
Need the numbers behind this tracker?
We assess compliance history and supply risk for API and formulation sourcing decisions.
Get the monthly India tracker updateNew state data and new plant announcements in one short email, once a month.
One email a month. Reply to any email to unsubscribe. Privacy policy